首页|期刊导航|中国神经再生研究（英文版）|Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases

Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases

Shiran Naftelberg Gil Ast Eran Perlson

中国神经再生研究（英文版）2017，Vol.12Issue(4)：534-537,4.

中国神经再生研究（英文版）2017，Vol.12Issue(4)：534-537,4.DOI:10.4103/1673-5374.205082

Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases

Shiran Naftelberg ¹Gil Ast ¹Eran Perlson²

作者信息

1. Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2. Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
折叠

摘要

关键词

axonal transport/neurodegeneration/microtubule/familial dysautonomia/phosphatidylserine/HDAC6

Key words

axonal transport/neurodegeneration/microtubule/familial dysautonomia/phosphatidylserine/HDAC6

引用本文复制引用

Shiran Naftelberg,Gil Ast,Eran Perlson..Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases[J].中国神经再生研究（英文版）,2017,12(4):534-537,4.

基金项目

Funding for this work was provided by grants from the Dysautonomia Foundation. Israel Science Foundation (ISF) [142/13, 1439/14], and by Teva Pharmaceutical Industries Ltd as part of the Israeli National Network of Excellence in Neuroscience (NNE) [1234944]. E.P. was supported by grants from the Israel Science Foundation (ISF) [561/11] （ISF）

and the European Research Council (ERC) [309377]. S.N. was supported by grants from Teva Pharmaceutical Industries Ltd. under the Israeli National Network of Excellence in Neuroscience. （ERC）

中国神经再生研究（英文版）

OACSCDCSTPCDSCI

ISSN：1673-5374

访问量1

下载量0

段落导航